| GILEAD SCIENCES DL-,001 |
| USA |
| Gesundheit |
| US3755581036 / 885823 |
| GIS (Frankfurt) / GILD (NASDAQ) |
| FRA:GIS, ETR:GIS, GIS:GR, NASDAQ:GILD |
| https://www.gilead.com/ |
|
Gilead Sciences Inc. is a biopharmaceutical compan..
>Volltext.. |
| 128826.03 Mio. EUR |
| 120834.18 Mio. EUR |
| 25168.69 Mio. EUR |
| - |
| 7029.1 Mio. EUR |
| 5.65 EUR |
| - |
| - |
| 8378.58 Mio. EUR |
| 0.76 |
| -2.55% |
| 6007.23% |
| 2.69 EUR |
| 2.62% |
| 2.64% |
| 15.09.25 - 0.67782€ 13.06.25 - 0.67782€ >weitere anzeigen... |
| GILEAD, REMDESIVIR |
| 02.11.25 |
|